Cargando…

Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study

Patients with post‐acute sequelae of COVID‐19 (PASC) present with a decrease in physical fitness. The aim of this paper is to reveal the relations between the remaining symptoms, blood volume distribution, exercise tolerance, static and dynamic lung volumes, and overall functioning. Patients with PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dierckx, Wendel, De Backer, Wilfried, Ides, Kris, De Meyer, Yinka, Lauwers, Eline, Franck, Erik, De Backer, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284821/
https://www.ncbi.nlm.nih.gov/pubmed/37344757
http://dx.doi.org/10.14814/phy2.15754
_version_ 1785061475495182336
author Dierckx, Wendel
De Backer, Wilfried
Ides, Kris
De Meyer, Yinka
Lauwers, Eline
Franck, Erik
De Backer, Jan
author_facet Dierckx, Wendel
De Backer, Wilfried
Ides, Kris
De Meyer, Yinka
Lauwers, Eline
Franck, Erik
De Backer, Jan
author_sort Dierckx, Wendel
collection PubMed
description Patients with post‐acute sequelae of COVID‐19 (PASC) present with a decrease in physical fitness. The aim of this paper is to reveal the relations between the remaining symptoms, blood volume distribution, exercise tolerance, static and dynamic lung volumes, and overall functioning. Patients with PASC were retrospectively studied. Pulmonary function tests (PFT), 6‐minute walk test (6MWT), and cardiopulmonary exercise test were performed. Chest CT was taken and quantified. Patients were divided into two groups: minor functional limitations (MFL) and severe functional limitations (SFL) based on the completed Post‐COVID‐19 Functional Status scale (PCFS). Twenty one patients (3 M; 18 FM), mean age 44 (IQR 21) were studied. Eighteen completed the PCFS (8 MFL; 10 SFL). VO(2)max was suboptimal in both groups (not significant). 6MWT was significantly higher in MFL‐group (p = 0.043). Subjects with SFL, had significant lower TLC (p = 0.029). The MFL‐group had more air trapping (p = 0.036). Throughout the sample, air trapping correlated significantly with residual volume (RV) in L (p < 0.001). An increase in air trapping was related to an increase in BV5 (p < 0.001). Mean BV5 was 65% (IQR 5%). BV5% in patients with PASC was higher than in patients with acute COVID‐19 infection. This increase in BV5% in patients with PASC is thought to be driven by the air trapping in the lobes. This study reveals that symptoms are more driven by occlusion of the small airways. Patients with more physical complaints have significantly lower TLC. All subjects encounter physical limitations as indicated by suboptimal VO(2)max. Treatment should focus on opening or re‐opening of small airways by recruiting alveoli.
format Online
Article
Text
id pubmed-10284821
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102848212023-06-23 Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study Dierckx, Wendel De Backer, Wilfried Ides, Kris De Meyer, Yinka Lauwers, Eline Franck, Erik De Backer, Jan Physiol Rep Original Articles Patients with post‐acute sequelae of COVID‐19 (PASC) present with a decrease in physical fitness. The aim of this paper is to reveal the relations between the remaining symptoms, blood volume distribution, exercise tolerance, static and dynamic lung volumes, and overall functioning. Patients with PASC were retrospectively studied. Pulmonary function tests (PFT), 6‐minute walk test (6MWT), and cardiopulmonary exercise test were performed. Chest CT was taken and quantified. Patients were divided into two groups: minor functional limitations (MFL) and severe functional limitations (SFL) based on the completed Post‐COVID‐19 Functional Status scale (PCFS). Twenty one patients (3 M; 18 FM), mean age 44 (IQR 21) were studied. Eighteen completed the PCFS (8 MFL; 10 SFL). VO(2)max was suboptimal in both groups (not significant). 6MWT was significantly higher in MFL‐group (p = 0.043). Subjects with SFL, had significant lower TLC (p = 0.029). The MFL‐group had more air trapping (p = 0.036). Throughout the sample, air trapping correlated significantly with residual volume (RV) in L (p < 0.001). An increase in air trapping was related to an increase in BV5 (p < 0.001). Mean BV5 was 65% (IQR 5%). BV5% in patients with PASC was higher than in patients with acute COVID‐19 infection. This increase in BV5% in patients with PASC is thought to be driven by the air trapping in the lobes. This study reveals that symptoms are more driven by occlusion of the small airways. Patients with more physical complaints have significantly lower TLC. All subjects encounter physical limitations as indicated by suboptimal VO(2)max. Treatment should focus on opening or re‐opening of small airways by recruiting alveoli. John Wiley and Sons Inc. 2023-06-21 /pmc/articles/PMC10284821/ /pubmed/37344757 http://dx.doi.org/10.14814/phy2.15754 Text en © 2023 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Dierckx, Wendel
De Backer, Wilfried
Ides, Kris
De Meyer, Yinka
Lauwers, Eline
Franck, Erik
De Backer, Jan
Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
title Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
title_full Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
title_fullStr Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
title_full_unstemmed Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
title_short Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
title_sort unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of covid‐19 (pasc): a retrospective study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284821/
https://www.ncbi.nlm.nih.gov/pubmed/37344757
http://dx.doi.org/10.14814/phy2.15754
work_keys_str_mv AT dierckxwendel unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy
AT debackerwilfried unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy
AT ideskris unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy
AT demeyeryinka unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy
AT lauwerseline unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy
AT franckerik unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy
AT debackerjan unravelingpathophysiologicmechanismscontributingtosymptomsinpatientswithpostacutesequelaeofcovid19pascaretrospectivestudy